Pfizer’s New Drug Slows Pancreatic Tumors

Pfizer’s experimental drug, CP- 870,893 slowed down pancreatic cancer significantly. The treatment tricks the immune system and shrinks pancreatic tumors by targeting the tissue around the cancer mass instead of the malignant cells. The method was tested on lab...